Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition

Withdrawn before enrolling · Phase 3 · Has a placebo group

Conditions studied: Functional Dyspepsia

In brief

The purpose of this study is to evaluate the effectiveness of gabapentin on symptom control in patients with defined functional dyspepsia refractory to conventional proton pump inhibitor therapy and to compare these effects to that of placebo.

Key facts

Study ID

NCT01052896

Run by

59th Medical Wing

People needed

0

Starts

2010-03-01

Expected to finish

2012-08-28

Last updated by the study team

2020-10-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients to be included in this study are adults (age >18 years) with defined functional dyspepsia per the ROME III criteria with a negative EGD who are on proton pump inhibitor therapy yet still have a sense of inadequate symptom control.

You may not qualify if…

• Patients excluded will be women of childbearing age who refuse to have a baseline pregnancy test and/or who refuse to prevent pregnancy during the trial period. Exclusion criteria will also include anyone with a history of adverse effect or allergy to gabapentin. Finally, any patient undergoing hemodialysis or with a history of creatinine chronically greater than 1.5 will be excluded.

Where it is running

• San Antonio Military Medical Center - North — San Antonio, Texas, United States
• San Antonio Military Medical Center - South — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.